Dalia Levine

Dalia Levine has a diverse work experience spanning over several decades. Dalia is currently working as a Senior Director, CMC at CinRx Pharma since 2022. Prior to this, Dalia held the same role at Atox Bio from 2017 to 2021, where they were responsible for developing novel small synthetic peptide immunomodulators for critically ill patients. At Atox Bio, they played a key role in filing a New Drug Application (NDA) for Reltecimod.

Before joining Atox Bio, Dalia worked as the Director of CMC and Formulations at Eloxx Pharmaceuticals from 2015 to 2017. Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing RNA-modulating drug candidates for rare diseases. Dalia also worked as a Research Scientist at Janssen, Pharmaceutical Companies of Johnson and Johnson in 2015.

Dalia's career also includes their tenure as a Research Scientist at Johnson & Johnson from 2009 to 2015. Dalia has been involved in various early phase programs and has made significant contributions to the company. Prior to that, they worked as a Development Work Stream Lead at Omrix Biopharmaceuticals from 2013 to 2014 and as a Research Scientist in Drug Product Development at Janssen Research and Development / Centocor from 2009 to 2013.

Dalia started their professional journey as a PhD Candidate in Chemical and Biomolecular Engineering at the University of Pennsylvania, where they conducted extensive research on the use of self-assembled polymeric vesicles and dendrimeric vesicles for cancer theranostic applications. Dalia also worked as a Staff Engineer at Merck from 2002 to 2004 and as a Summer Student Researcher at Technion - Israel Institute of Technology in 1996.

Overall, Dalia Levine's work experience showcases their expertise in CMC, drug development, and research in the pharmaceutical industry.

Dalia Levine's education history includes obtaining a PhD in Chemical and Biomolecular Engineering from the University of Pennsylvania from 2004 to 2009. Prior to that, they earned an MS in Chemical and Biomolecular Engineering from the same university from 2004 to 2007. Dalia also holds a Bachelor of Engineering (BE) degree in Chemical Engineering from The Cooper Union for the Advancement of Science and Art, which they obtained from 1997 to 2002. Dalia participated in an overseas program at Tel Aviv University from 1999 to 2000. Before their higher education, Dalia attended Cold Spring Harbor HS from 1991 to 1997, although no degree or field of study information is available for this period.